Search Results - "Boon, Louis"
-
1
An intrinsic role of IL-33 in Treg cell–mediated tumor immunoevasion
Published in Nature immunology (2020)“…Regulatory T (T reg ) cells accumulate into tumors, hindering the success of cancer immunotherapy. Yet, therapeutic targeting of T reg cells shows limited…”
Get full text
Journal Article -
2
The tumour microenvironment harbours ontogenically distinct dendritic cell populations with opposing effects on tumour immunity
Published in Nature communications (23-12-2016)“…Various steady state and inflamed tissues have been shown to contain a heterogeneous DC population consisting of developmentally distinct subsets, including…”
Get full text
Journal Article -
3
Newcastle disease virotherapy induces long‐term survival and tumor‐specific immune memory in orthotopic glioma through the induction of immunogenic cell death
Published in International journal of cancer (01-03-2015)“…The oncolytic features of several naturally oncolytic viruses have been shown on Glioblastoma Multiforme cell lines and in xenotransplant models. However,…”
Get full text
Journal Article -
4
Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis
Published in The Journal of immunology (1950) (01-05-2009)“…Topical application of imiquimod (IMQ), a TLR7/8 ligand and potent immune activator, can induce and exacerbate psoriasis, a chronic inflammatory skin disorder…”
Get full text
Journal Article -
5
Type 3 innate lymphoid cells maintain intestinal epithelial stem cells after tissue damage
Published in The Journal of experimental medicine (19-10-2015)“…Disruption of the intestinal epithelial barrier allows bacterial translocation and predisposes to destructive inflammation. To ensure proper barrier…”
Get full text
Journal Article -
6
Ablation of NLRP3 inflammasome rewires MDSC function and promotes tumor regression
Published in Frontiers in immunology (10-08-2022)“…Myeloid-derived suppressor cells (MDSCs) are myeloid precursors that exert potent immunosuppressive properties in cancer. Despite the extensive knowledge on…”
Get full text
Journal Article -
7
Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy
Published in Scientific reports (27-04-2017)“…In this study, we evaluated the consequences of reducing Galectin-1 (Gal-1) in the tumor micro-environment (TME) of glioblastoma multiforme (GBM), via…”
Get full text
Journal Article -
8
PD-1 Is Involved in the Dysregulation of Type 2 Innate Lymphoid Cells in a Murine Model of Obesity
Published in Cell reports (Cambridge) (20-11-2018)“…Recent observations clearly highlight the critical role of type 2 innate lymphoid cells in maintaining the homeostasis of adipose tissues in humans and mice…”
Get full text
Journal Article -
9
Dual blockage of both PD-L1 and CD47 enhances the therapeutic effect of oxaliplatin and FOLFOX in CT-26 mice tumor model
Published in Scientific reports (11-02-2023)“…Colorectal cancer is a poorly immunogenic. Such property can be reverted by using ICD. However, ICD inducers can also induce the expression of inhibitory…”
Get full text
Journal Article -
10
IL-23-mediated mononuclear phagocyte crosstalk protects mice from Citrobacter rodentium-induced colon immunopathology
Published in Nature communications (12-03-2015)“…Gut homeostasis and mucosal immune defense rely on the differential contributions of dendritic cells (DC) and macrophages. Here we show that colonic CX 3 CR1 +…”
Get full text
Journal Article -
11
Temporally restricted activation of IFNβ signaling underlies response to immune checkpoint therapy in mice
Published in Nature communications (19-08-2022)“…The biological determinants of the response to immune checkpoint blockade (ICB) in cancer remain incompletely understood. Little is known about dynamic…”
Get full text
Journal Article -
12
Regulatory Role for NK Cells in a Mouse Model of Systemic Juvenile Idiopathic Arthritis
Published in The Journal of immunology (1950) (15-12-2019)“…Mice deficient in IFN-γ (IFN-γ knockout [KO] mice) develop a systemic inflammatory syndrome in response to CFA, in contrast to CFA-challenged wild-type (WT)…”
Get full text
Journal Article -
13
Cooperation of Oncolytic Herpes Virotherapy and PD-1 Blockade in Murine Rhabdomyosarcoma Models
Published in Scientific reports (24-05-2017)“…Oncolytic virotherapy is an effective immunotherapeutic approach for cancer treatment via a multistep process including direct tumor cell lysis, induction of…”
Get full text
Journal Article -
14
Antitumor immunity triggered by melphalan is potentiated by melanoma cell surface-associated calreticulin
Published in Cancer research (Chicago, Ill.) (15-04-2015)“…Systemic chemotherapy generally has been considered immunosuppressive, but it has become evident that certain chemotherapeutic drugs elicit immunogenic danger…”
Get full text
Journal Article -
15
Collagen Fragments Produced in Cancer Mediate T Cell Suppression Through Leukocyte-Associated Immunoglobulin-Like Receptor 1
Published in Frontiers in immunology (07-10-2021)“…The tumor microenvironment (TME) is a complex structure comprised of tumor, immune and stromal cells, vasculature, and extracellular matrix (ECM). During tumor…”
Get full text
Journal Article -
16
Immunological synapse formation between T regulatory cells and cancer-associated fibroblasts promotes tumour development
Published in Nature communications (11-06-2024)“…Cancer-associated fibroblasts (CAFs) have emerged as a dominant non-hematopoietic cell population in the tumour microenvironment, serving diverse functions in…”
Get full text
Journal Article -
17
Innate and adaptive type 2 immune cell responses in genetically controlled resistance to intestinal helminth infection
Published in Immunology and cell biology (01-05-2014)“…The nematode Heligmosomoides polygyrus is an excellent model for intestinal helminth parasitism. Infection in mice persists for varying lengths of time in…”
Get full text
Journal Article -
18
Preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma
Published in Oncoimmunology (03-04-2017)“…Glioblastoma (GBM) is resistant to most multimodal therapies. Clinical success of immune-checkpoint inhibitors (ICIs) has spurred interest in applying ICIs…”
Get full text
Journal Article -
19
High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9–TRIF pathway
Published in Nature communications (14-05-2013)“…CpG-rich oligodeoxynucleotides activate the immune system, leading to innate and acquired immune responses. The immune-stimulatory effects of CpG-rich…”
Get full text
Journal Article -
20
Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis
Published in Blood (18-11-2010)“…CD40 ligand (CD40L), identified as a costimulatory molecule expressed on T cells, is also expressed and functional on platelets. We investigated the thrombotic…”
Get full text
Journal Article